Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cue Biopharma Inc buy Oppenheimer Holdings Inc.

Start price
€3.00
22.03.23 / 50%
Target price
€9.27
22.03.24
Performance (%)
-42.17%
End price
€1.74
23.03.24
Summary
This prediction ended on 23.03.24 with a price of €1.74. The BUY prediction by Oppenheimer_Holdings for Cue Biopharma Inc performed very badly with a performance of -42.17%. Oppenheimer_Holdings has a follow-up prediction for Cue Biopharma Inc where he still thinks Cue Biopharma Inc is a Buy. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cue Biopharma Inc -20.112% -20.112% -63.333%
iShares Core DAX® 1.851% 5.158% 17.711%
iShares Nasdaq 100 1.573% 2.589% 39.053%
iShares Nikkei 225® -0.412% -2.857% 13.501%
iShares S&P 500 1.128% 2.485% 29.871%

Comments by Oppenheimer_Holdings for this prediction

In the thread Cue Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -42.17%
Target price 9.272
Change
Ends at 22.03.24

Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Ratings data for CUE provided by MarketBeat

In the thread Trading Cue Biopharma Inc
Prediction Buy
Perf. (%) -42.17%
Target price 9.272
Change
Ends at 22.03.24

Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten

Current prediction by Oppenheimer_Holdings for Cue Biopharma Inc

buy
Cue Biopharma Inc

Start price
Target price
Perf. (%)
€1.65
09.04.24
€9.19
09.04.25
-13.33%
14.05.24